Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tonghua Shenyuan Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company based in Tonghua, Jilin Province, specializing in the development and manufacture of traditional Chinese medicine (TCM) and botanical-based therapeutics. Founded in 1993, the company is best known for its flagship product, Xiaoaiping Injection, a botanical extract derived from Marsdenia tenacissima that is widely used in China for the treatment of various cancers, including lung, gastric, and esophageal cancer. The company operates within the Tonghua pharmaceutical cluster and has established a significant presence in the oncology market through its focus on herbal-based anti-tumor therapies. Tonghua Shenyuan's business encompasses the entire value chain from research and development to large-scale production and commercialization of its proprietary formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenyuan Pharmaceutical.